189 related articles for article (PubMed ID: 35951632)
1. Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients.
Tekle E; Gelaw Y; Dagnew M; Gelaw A; Negash M; Kassa E; Bizuneh S; Wudineh D; Asrie F
PLoS One; 2022; 17(8):e0272216. PubMed ID: 35951632
[TBL] [Abstract][Full Text] [Related]
2. Baseline Thrombocytopenia and Disease Severity Among COVID-19 Patients, Tibebe Ghion Specialized Hospital COVID-19 Treatment Center, Northwest Ethiopia.
Asrie F; Tekle E; Gelaw Y; Dagnew M; Gelaw A; Negash M; Kassa E; Bizuneh S; Wudineh D
J Blood Med; 2022; 13():315-325. PubMed ID: 35712680
[TBL] [Abstract][Full Text] [Related]
3. Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia.
Araya S; Mamo MA; Tsegay YG; Atlaw A; Aytenew A; Hordofa A; Negeso AE; Wordofa M; Niguse T; Cheru M; Tamir Z
PLoS One; 2021; 16(6):e0252939. PubMed ID: 34153056
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic Value of Prothrombin Time and Activated Partial Thromboplastin Time in Newly Diagnosed Patients with Multiple Myeloma].
Wang LJ; Han MR; Dong CX; Tian WW; Lu XY; Yang LH; Ma YP; Wang MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):805-810. PubMed ID: 38926971
[TBL] [Abstract][Full Text] [Related]
5. D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis.
Long H; Nie L; Xiang X; Li H; Zhang X; Fu X; Ren H; Liu W; Wang Q; Wu Q
Biomed Res Int; 2020; 2020():6159720. PubMed ID: 32596339
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
Tseng LW; Hughes D; Giger U
Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
[TBL] [Abstract][Full Text] [Related]
7. Exploring coagulation parameters as predictive biomarkers of Plasmodium infection: A comprehensive analysis of coagulation parameters.
Tesfaye Z; Derso A; Zeleke AJ; Addisu A; Woldu B; Deress T; Mekonnen GG; Tegegne Y
PLoS One; 2024; 19(4):e0301963. PubMed ID: 38626035
[TBL] [Abstract][Full Text] [Related]
8. Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome.
Idowu OE; Oyeleke SO; Vitowanu JM
Eur J Trauma Emerg Surg; 2022 Apr; 48(2):1085-1092. PubMed ID: 33839805
[TBL] [Abstract][Full Text] [Related]
9. Association between activated partial thromboplastin time, age and bleeding events in NVAF patients receiving dabigatran.
Ji Q; Xu Q; Wang Z; Li X; Lv Q
Eur J Clin Pharmacol; 2019 Mar; 75(3):321-328. PubMed ID: 30377709
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective cohort study on the coagulation characteristics of adult patients with extensively severe burn in shock stage and its alarming value].
Ma QM; Liu XB; Wu GS; Hou WJ; Fan XM; Shen T; Wang KA; Zhu F
Zhonghua Shao Shang Za Zhi; 2021 Feb; 37(2):150-156. PubMed ID: 33498103
[No Abstract] [Full Text] [Related]
11. [A new warning scoring system establishment for prediction of sepsis in patients with trauma in intensive care unit].
Huang Q; Sun Y; Luo L; Meng S; Chen T; Ai S; Jiang D; Liang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Apr; 31(4):422-427. PubMed ID: 31109414
[TBL] [Abstract][Full Text] [Related]
12. Would Tracking Coagulation Together with Inflamation Markers be a Prospect for COVID-19 Disease Prognosis?
Medetalibeyoglu A; Kaytaz M; Senkal N; Genc S; Aktar I; Omer B; Oncul O; Tukek T
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704730
[TBL] [Abstract][Full Text] [Related]
13. Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis.
Yuan Y; Li X; Qiu F
Clin Appl Thromb Hemost; 2023; 29():10760296231178546. PubMed ID: 37271988
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of routine coagulation tests for patients with heat stroke.
Xing L; Liu SY; Mao HD; Zhou KG; Song Q; Cao QM
Am J Emerg Med; 2021 Jun; 44():366-372. PubMed ID: 32389399
[TBL] [Abstract][Full Text] [Related]
15. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
[TBL] [Abstract][Full Text] [Related]
16. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma.
Geng C; Yang G; Wang H; Zhang Z; Zhou H; Chen W
Biomed Res Int; 2021; 2021():6689457. PubMed ID: 34104651
[TBL] [Abstract][Full Text] [Related]
18. [Combined predictive value of the risk factors influencing the short-term prognosis of sepsis].
Chen R; Zhou X; Rui Q; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):307-312. PubMed ID: 32385994
[TBL] [Abstract][Full Text] [Related]
19. Role of Coagulation Profile in Predicting Disease Severity Among Patients of COVID-19.
Saurabh A; Dey B; Raphael V; Deb P; Khonglah Y; Tiewsoh I
Cureus; 2021 Oct; 13(10):e19124. PubMed ID: 34858762
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass.
Nuttall GA; Oliver WC; Beynen FM; Dull JJ; Murray MJ; Nichols WL
J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):402-9. PubMed ID: 8400094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
